These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum. Isakov O; Bordería AV; Golan D; Hamenahem A; Celniker G; Yoffe L; Blanc H; Vignuzzi M; Shomron N Bioinformatics; 2015 Jul; 31(13):2141-50. PubMed ID: 25701575 [TBL] [Abstract][Full Text] [Related]
25. [An analysis of the possible routes of viral macroevolution]. Kibardin VM; Nazarova GM Vopr Virusol; 1991; 36(6):460-3. PubMed ID: 1785178 [TBL] [Abstract][Full Text] [Related]
26. Paleovirology - ghosts and gifts of viruses past. Patel MR; Emerman M; Malik HS Curr Opin Virol; 2011 Oct; 1(4):304-9. PubMed ID: 22003379 [TBL] [Abstract][Full Text] [Related]
27. Antiviral research--21st international conference. Turner B IDrugs; 2008 Jun; 11(6):401-4. PubMed ID: 18509777 [No Abstract] [Full Text] [Related]
28. Qualitative study of drug resistance in retroviral protease using structural modeling and site-directed mutagenesis. Culberson JC; Bush BL; Sardana VV Methods Enzymol; 1994; 241():385-94. PubMed ID: 7854190 [No Abstract] [Full Text] [Related]
29. Antiviral drug discovery targeting to viral proteases. Hsu JT; Wang HC; Chen GW; Shih SR Curr Pharm Des; 2006; 12(11):1301-14. PubMed ID: 16611117 [TBL] [Abstract][Full Text] [Related]
30. Resistance to antiretroviral drugs. Calvez V Antivir Ther; 1998; 3 Suppl 4():5-7. PubMed ID: 10723502 [TBL] [Abstract][Full Text] [Related]
31. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants. Khandelwal N; Chander Y; Rawat KD; Riyesh T; Nishanth C; Sharma S; Jindal N; Tripathi BN; Barua S; Kumar N Antiviral Res; 2017 Aug; 144():196-204. PubMed ID: 28624461 [TBL] [Abstract][Full Text] [Related]
32. Utility of leukemogenic viruses for testing antiviral agents in vivo. Chirigos MA Ann N Y Acad Sci; 1965 Jul; 130(1):56-64. PubMed ID: 5216632 [No Abstract] [Full Text] [Related]
33. On the evolution of sex in RNA viruses. Nee S J Theor Biol; 1989 Jun; 138(3):407-12. PubMed ID: 2593681 [No Abstract] [Full Text] [Related]
34. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Geller R; Vignuzzi M; Andino R; Frydman J Genes Dev; 2007 Jan; 21(2):195-205. PubMed ID: 17234885 [TBL] [Abstract][Full Text] [Related]
35. Quasispecies and the development of new antiviral strategies. Domingo E Prog Drug Res; 2003; 60():133-58. PubMed ID: 12790341 [TBL] [Abstract][Full Text] [Related]
36. Rates of evolutionary change in viruses: patterns and determinants. Duffy S; Shackelton LA; Holmes EC Nat Rev Genet; 2008 Apr; 9(4):267-76. PubMed ID: 18319742 [TBL] [Abstract][Full Text] [Related]
37. Molecular biology of fish viruses: a review. Bernard J; Brémont M Vet Res; 1995; 26(5-6):341-51. PubMed ID: 8581005 [TBL] [Abstract][Full Text] [Related]
38. The variety of human virus evolution. Fitch WM Mol Phylogenet Evol; 1996 Feb; 5(1):247-58. PubMed ID: 8673293 [TBL] [Abstract][Full Text] [Related]
39. Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis. Ghedin E; Pumfery A; de la Fuente C; Yao K; Miller N; Lacoste V; Quackenbush J; Jacobson S; Kashanchi F Retrovirology; 2004 May; 1():10. PubMed ID: 15169557 [TBL] [Abstract][Full Text] [Related]
40. Molecular approaches to inhibit oncogenesis by RNA tumor viruses. Chandra P; Ebener U; Steel LK; Laube H; Gericke D; Mildner B; Bardos TJ; Ho YK; Götz A Ann N Y Acad Sci; 1977 Mar; 284():444-62. PubMed ID: 280144 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]